Discovery Therapeutics Caribe Receives Study May Proceed Letter from FDA to initiate a Phase 3 Clinical Trial of intralesional rhEGF for the treatment of diabetic foot ulcers
30. April 2024 09:00 ET
|
Discovery Therapeutics Caribe, LLC
FDA approves Discovery Therapeutic Caribe's Phase 3 trial for intralesional rhEGF in severe diabetic foot ulcers.
Diabetic Foot Ulcer Market Worth $12.24 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
27. September 2023 10:28 ET
|
The Insight Partners
Pune, India, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. Diabetic foot ulcer...
With 5.9 % CAGR, Diabetic Foot Ulcer Treatment Market Size worth USD 11.05 billion by 2027
01. September 2022 06:00 ET
|
Fortune Business Insights
Pune, India, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The global diabetic foot ulcer treatment market size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes...
MicroGenDX First Independent Commercial Lab in US Offering NGS for Infections to Appeal Directly to Patients
24. Januar 2022 18:07 ET
|
Microgen Diagnostics
ORLANDO, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Using national TV, radio, and web media campaigns, Microgen Diagnostics will be the first independent commercial lab in the U.S. to appeal directly...
Diabetic Foot Ulcer Treatment Market Worth USD 11.05 Billion at 5.9% CAGR; Rising Adoption of Novel Wound Care Devices to Propel Growth: Fortune Business Insights™
25. Mai 2021 06:04 ET
|
Fortune Business Insights
Pune, India, May 25, 2021 (GLOBE NEWSWIRE) -- The global “diabetic foot ulcer treatment market” size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes...
Shareholder Update Q3 2018
02. Oktober 2018 00:00 ET
|
Factor Therapeutics
Highlights: Venous leg ulcer Phase 2 trial on track: top-line results mid-NovemberDiabetic foot ulcer pilot clinical study: in development with key US researchersOcular wounds: international patent...